Outlook Therapeutics, Inc. · NASDAQ:OTLK
Haddadin Yezan Munther bought 34,000 Outlook Therapeutics, Inc. shares (Form 4)
Traded May 26, 2026 · Filed May 27, 2026
On May 26, 2026, Haddadin Yezan Munther (Director) bought 34,000 Outlook Therapeutics, Inc. shares at US$0.44 for US$14,960, leaving 37,167 shares. Filed May 27, 2026 (Form 4).
- Bought
- 34,000 shares
- Price
- US$0.44
- Value
- US$14,960
- Holding after
- 37,167 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 26, 2026 | Common Stock | Buy | 34,000 | US$0.44 | 37,167 | Direct |
Source
Related
- Outlook Therapeutics, Inc.
- Haddadin Yezan Munther
- Outlook Therapeutics, Inc. shareholders
- Form 4 · Haddadin Yezan Munther · Jun 3, 2026
- Schedule 13G · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · CVI Investments, Inc. · Aug 19, 2026
- Form 4 · Jahr Robert Charles · Aug 14, 2026
- Form 4 · Kenyon Lawrence A · Aug 14, 2026
- Form 4 · Sukhtian Ghiath M. · Aug 14, 2026